Telesis Bio (TBIO) Competitors $0.47 -0.09 (-16.07%) (As of 12/20/2024 03:47 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrends TBIO vs. TLIS, SPEC, THMO, OLITW, PRENW, QSIAW, SMAPW, TT, KEYS, and FTVShould you be buying Telesis Bio stock or one of its competitors? The main competitors of Telesis Bio include Talis Biomedical (TLIS), Spectaire (SPEC), ThermoGenesis (THMO), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), Keysight Technologies (KEYS), and Fortive (FTV). These companies are all part of the "measuring and control equipment" industry. Telesis Bio vs. Talis Biomedical Spectaire ThermoGenesis OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Fortive Telesis Bio (NASDAQ:TBIO) and Talis Biomedical (NASDAQ:TLIS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation. Which has higher valuation and earnings, TBIO or TLIS? Telesis Bio has higher revenue and earnings than Talis Biomedical. Talis Biomedical is trading at a lower price-to-earnings ratio than Telesis Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTelesis Bio$225.09M0.00-$47.72M-$28.20-0.02Talis Biomedical$300K10.50-$62.01M-$28.02-0.06 Is TBIO or TLIS more profitable? Telesis Bio has a net margin of -336.59% compared to Talis Biomedical's net margin of -5,784.73%. Talis Biomedical's return on equity of -79.74% beat Telesis Bio's return on equity.Company Net Margins Return on Equity Return on Assets Telesis Bio-336.59% -359.32% -61.89% Talis Biomedical -5,784.73%-79.74%-57.16% Does the MarketBeat Community favor TBIO or TLIS? Telesis Bio and Talis Biomedical both received 9 outperform votes by MarketBeat users. However, 52.94% of users gave Telesis Bio an outperform vote while only 37.50% of users gave Talis Biomedical an outperform vote. CompanyUnderperformOutperformTelesis BioOutperform Votes952.94% Underperform Votes847.06% Talis BiomedicalOutperform Votes937.50% Underperform Votes1562.50% Which has more volatility & risk, TBIO or TLIS? Telesis Bio has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Comparatively, Talis Biomedical has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Do institutionals & insiders believe in TBIO or TLIS? 37.6% of Telesis Bio shares are owned by institutional investors. Comparatively, 43.8% of Talis Biomedical shares are owned by institutional investors. 24.5% of Telesis Bio shares are owned by company insiders. Comparatively, 46.0% of Talis Biomedical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media prefer TBIO or TLIS? In the previous week, Telesis Bio's average media sentiment score of 0.00 equaled Talis Biomedical'saverage media sentiment score. Company Overall Sentiment Telesis Bio Neutral Talis Biomedical Neutral SummaryTalis Biomedical beats Telesis Bio on 6 of the 11 factors compared between the two stocks. Ad Behind the MarketsWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> Get Telesis Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TBIO vs. The Competition Export to ExcelMetricTelesis BioAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$994,000.00$5.42B$5.14B$9.08BDividend YieldN/A0.43%5.09%4.23%P/E Ratio-0.0225.1890.1317.20Price / Sales0.004.291,117.09117.04Price / CashN/A44.4543.1037.85Price / Book3.362.204.784.78Net Income-$47.72M$2.05M$120.31M$225.60M7 Day Performance17.50%-2.70%-1.92%-1.23%1 Month Performance-48.35%-4.22%13.65%0.46%1 Year Performance-93.30%-29.70%28.34%15.24% Telesis Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TBIOTelesis BioN/A$0.47-16.1%N/A-92.5%$994,000.00$225.09M-0.02200TLISTalis BiomedicalN/A$1.70-0.6%N/A-78.5%$3.09M$2.13M-0.06260SPECSpectaireN/A$0.02+12.4%N/A-99.0%$350,000.00N/A0.008Gap UpTHMOThermoGenesisN/A$0.00flatN/A-99.9%$4,000.00$9.61M0.0025OLITWOmniLit AcquisitionN/A$0.08+33.3%N/A+104.0%$0.00N/A0.003Gap UpHigh Trading VolumePRENWPrenetics GlobalN/A$0.01-17.2%N/AN/A$0.00$25.56M0.001Positive NewsGap DownQSIAWQuantum-SiN/A$0.47+10.1%N/A+79.4%$0.00$2.27M0.00159Gap UpHigh Trading VolumeSMAPWSportsMap Tech AcquisitionN/A$0.02+1.6%N/AN/A$0.00N/A0.00N/AGap UpTTTrane Technologies4.0789 of 5 stars$398.68-0.2%$409.93+2.8%+54.9%$89.71B$19.39B37.0540,000Positive NewsKEYSKeysight Technologies4.8394 of 5 stars$171.00+2.7%$180.80+5.7%+2.8%$29.68B$4.98B49.0414,900Analyst RevisionFTVFortive4.7344 of 5 stars$76.76-0.1%$86.73+13.0%+2.6%$26.63B$6.20B30.5518,000Analyst Forecast Related Companies and Tools Related Companies Talis Biomedical Competitors Spectaire Competitors ThermoGenesis Competitors OmniLit Acquisition Competitors Prenetics Global Competitors Quantum-Si Competitors SportsMap Tech Acquisition Competitors Trane Technologies Competitors Keysight Technologies Competitors Fortive Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TBIO) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telesis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telesis Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.